Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Interest & Investment Income: 2013-2025

Historic Interest & Investment Income for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Sep 2025 value amounting to $2.2 million.

  • Amphastar Pharmaceuticals' Interest & Investment Income fell 7.46% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 19.53%. This contributed to the annual value of $10.6 million for FY2024, which is 94.39% up from last year.
  • Amphastar Pharmaceuticals' Interest & Investment Income amounted to $2.2 million in Q3 2025, which was up 16.92% from $1.9 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Interest & Investment Income high stood at $3.3 million for Q2 2024, and its period low was $141,000 during Q3 2021.
  • For the 3-year period, Amphastar Pharmaceuticals' Interest & Investment Income averaged around $2.0 million, with its median value being $2.2 million (2025).
  • In the last 5 years, Amphastar Pharmaceuticals' Interest & Investment Income skyrocketed by 410.50% in 2023 and then crashed by 42.43% in 2025.
  • Amphastar Pharmaceuticals' Interest & Investment Income (Quarterly) stood at $157,000 in 2021, then spiked by 269.43% to $580,000 in 2022, then spiked by 297.07% to $2.3 million in 2023, then decreased by 0.48% to $2.3 million in 2024, then dropped by 7.46% to $2.2 million in 2025.
  • Its Interest & Investment Income was $2.2 million in Q3 2025, compared to $1.9 million in Q2 2025 and $2.1 million in Q1 2025.